PIM
PFE icon

Partner Investment Management’s Pfizer PFE Stock Holding History

Partner Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-23,926
Closed -$983K – 90
2019
Q2 		$983K Buy
+23,926
New +$950K 1.04% 38
2017
Q4 		– Sell
-120,367
Closed -$4.08M – 89
2017
Q3 		$4.08M Buy
+120,367
New +$3.87M 3.87% 4
2015
Q4 		– Sell
-52,278
Closed -$6K – 80
2015
Q3 		$6K Buy
+52,278
New +$1.68M 0.01% 68

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Partner Investment Management's PFE Position: Q4 2019 in Review

Partner Investment Management opened a new position in Pfizer (PFE) in Q4 2019: 7,897 shares worth $294K. The stake represents 2.11% of the portfolio and ranks #20 among its holdings. This is a return to the name: Partner Investment Management previously reported a position in PFE as recently as Q2 2019.

Partner Investment Management first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. The position peaked at $26.6M in Q2 2013. 2,525 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

  • Partner Investment Management held 7,897 shares of Pfizer worth $294K as of Q4 2019.
  • Pfizer was a new Partner Investment Management position in Q4 2019.
  • Pfizer made up 2.11% of Partner Investment Management's portfolio in Q4 2019, its #20 holding.
  • Partner Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
  • Partner Investment Management's Pfizer position peaked at $26.6M in Q2 2013.
  • 2,525 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.